Pfizer, Moderna vaccines cut COVID-19 risk by 91 per cent: Study

The research, published in the New England Journal of Medicine on June 30, is among the first to show the benefits of mRNA vaccines even among those who experience breakthrough infections -- testing positive after immunisation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3hH1Xzo
via IFTTT